Copyright Reports & Markets. All rights reserved.

Global Tumor Treatment Drug Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Tumor Treatment Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Chemotherapy
    • 1.2.3 Targeted Therapy
    • 1.2.4 Immunotherapy (Biologic Therapy)
    • 1.2.5 Hormonal Therapy
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Tumor Treatment Drug Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Blood Cancer
    • 1.3.3 Breast Cancer
    • 1.3.4 Gastrointestinal Cancer
    • 1.3.5 Prostate Cancer
    • 1.3.6 Respiratory/Lung Cancer
    • 1.3.7 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Tumor Treatment Drug Market Perspective (2016-2027)
  • 2.2 Tumor Treatment Drug Growth Trends by Regions
    • 2.2.1 Tumor Treatment Drug Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Tumor Treatment Drug Historic Market Share by Regions (2016-2021)
    • 2.2.3 Tumor Treatment Drug Forecasted Market Size by Regions (2022-2027)
  • 2.3 Tumor Treatment Drug Industry Dynamic
    • 2.3.1 Tumor Treatment Drug Market Trends
    • 2.3.2 Tumor Treatment Drug Market Drivers
    • 2.3.3 Tumor Treatment Drug Market Challenges
    • 2.3.4 Tumor Treatment Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Tumor Treatment Drug Players by Revenue
    • 3.1.1 Global Top Tumor Treatment Drug Players by Revenue (2016-2021)
    • 3.1.2 Global Tumor Treatment Drug Revenue Market Share by Players (2016-2021)
  • 3.2 Global Tumor Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Tumor Treatment Drug Revenue
  • 3.4 Global Tumor Treatment Drug Market Concentration Ratio
    • 3.4.1 Global Tumor Treatment Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Tumor Treatment Drug Revenue in 2020
  • 3.5 Tumor Treatment Drug Key Players Head office and Area Served
  • 3.6 Key Players Tumor Treatment Drug Product Solution and Service
  • 3.7 Date of Enter into Tumor Treatment Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Treatment Drug Breakdown Data by Type

  • 4.1 Global Tumor Treatment Drug Historic Market Size by Type (2016-2021)
  • 4.2 Global Tumor Treatment Drug Forecasted Market Size by Type (2022-2027)

5 Tumor Treatment Drug Breakdown Data by Application

  • 5.1 Global Tumor Treatment Drug Historic Market Size by Application (2016-2021)
  • 5.2 Global Tumor Treatment Drug Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Tumor Treatment Drug Market Size (2016-2027)
  • 6.2 North America Tumor Treatment Drug Market Size by Type
    • 6.2.1 North America Tumor Treatment Drug Market Size by Type (2016-2021)
    • 6.2.2 North America Tumor Treatment Drug Market Size by Type (2022-2027)
    • 6.2.3 North America Tumor Treatment Drug Market Size by Type (2016-2027)
  • 6.3 North America Tumor Treatment Drug Market Size by Application
    • 6.3.1 North America Tumor Treatment Drug Market Size by Application (2016-2021)
    • 6.3.2 North America Tumor Treatment Drug Market Size by Application (2022-2027)
    • 6.3.3 North America Tumor Treatment Drug Market Size by Application (2016-2027)
  • 6.4 North America Tumor Treatment Drug Market Size by Country
    • 6.4.1 North America Tumor Treatment Drug Market Size by Country (2016-2021)
    • 6.4.2 North America Tumor Treatment Drug Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Tumor Treatment Drug Market Size (2016-2027)
  • 7.2 Europe Tumor Treatment Drug Market Size by Type
    • 7.2.1 Europe Tumor Treatment Drug Market Size by Type (2016-2021)
    • 7.2.2 Europe Tumor Treatment Drug Market Size by Type (2022-2027)
    • 7.2.3 Europe Tumor Treatment Drug Market Size by Type (2016-2027)
  • 7.3 Europe Tumor Treatment Drug Market Size by Application
    • 7.3.1 Europe Tumor Treatment Drug Market Size by Application (2016-2021)
    • 7.3.2 Europe Tumor Treatment Drug Market Size by Application (2022-2027)
    • 7.3.3 Europe Tumor Treatment Drug Market Size by Application (2016-2027)
  • 7.4 Europe Tumor Treatment Drug Market Size by Country
    • 7.4.1 Europe Tumor Treatment Drug Market Size by Country (2016-2021)
    • 7.4.2 Europe Tumor Treatment Drug Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Tumor Treatment Drug Market Size (2016-2027)
  • 8.2 Asia-Pacific Tumor Treatment Drug Market Size by Type
    • 8.2.1 Asia-Pacific Tumor Treatment Drug Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Tumor Treatment Drug Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Tumor Treatment Drug Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Tumor Treatment Drug Market Size by Application
    • 8.3.1 Asia-Pacific Tumor Treatment Drug Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Tumor Treatment Drug Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Tumor Treatment Drug Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Tumor Treatment Drug Market Size by Region
    • 8.4.1 Asia-Pacific Tumor Treatment Drug Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Tumor Treatment Drug Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Tumor Treatment Drug Market Size (2016-2027)
  • 9.2 Latin America Tumor Treatment Drug Market Size by Type
    • 9.2.1 Latin America Tumor Treatment Drug Market Size by Type (2016-2021)
    • 9.2.2 Latin America Tumor Treatment Drug Market Size by Type (2022-2027)
    • 9.2.3 Latin America Tumor Treatment Drug Market Size by Type (2016-2027)
  • 9.3 Latin America Tumor Treatment Drug Market Size by Application
    • 9.3.1 Latin America Tumor Treatment Drug Market Size by Application (2016-2021)
    • 9.3.2 Latin America Tumor Treatment Drug Market Size by Application (2022-2027)
    • 9.3.3 Latin America Tumor Treatment Drug Market Size by Application (2016-2027)
  • 9.4 Latin America Tumor Treatment Drug Market Size by Country
    • 9.4.1 Latin America Tumor Treatment Drug Market Size by Country (2016-2021)
    • 9.4.2 Latin America Tumor Treatment Drug Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Tumor Treatment Drug Market Size (2016-2027)
  • 10.2 Middle East & Africa Tumor Treatment Drug Market Size by Type
    • 10.2.1 Middle East & Africa Tumor Treatment Drug Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Tumor Treatment Drug Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Tumor Treatment Drug Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Tumor Treatment Drug Market Size by Application
    • 10.3.1 Middle East & Africa Tumor Treatment Drug Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Tumor Treatment Drug Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Tumor Treatment Drug Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Tumor Treatment Drug Market Size by Country
    • 10.4.1 Middle East & Africa Tumor Treatment Drug Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Tumor Treatment Drug Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Tumor Treatment Drug Introduction
    • 11.1.4 Roche Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.1.5 Roche Recent Development
  • 11.2 Celgene
    • 11.2.1 Celgene Company Details
    • 11.2.2 Celgene Business Overview
    • 11.2.3 Celgene Tumor Treatment Drug Introduction
    • 11.2.4 Celgene Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.2.5 Celgene Recent Development
  • 11.3 Novartis
    • 11.3.1 Novartis Company Details
    • 11.3.2 Novartis Business Overview
    • 11.3.3 Novartis Tumor Treatment Drug Introduction
    • 11.3.4 Novartis Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.3.5 Novartis Recent Development
  • 11.4 Bristol-Myers Squibb
    • 11.4.1 Bristol-Myers Squibb Company Details
    • 11.4.2 Bristol-Myers Squibb Business Overview
    • 11.4.3 Bristol-Myers Squibb Tumor Treatment Drug Introduction
    • 11.4.4 Bristol-Myers Squibb Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.4.5 Bristol-Myers Squibb Recent Development
  • 11.5 Johnson & Johnson
    • 11.5.1 Johnson & Johnson Company Details
    • 11.5.2 Johnson & Johnson Business Overview
    • 11.5.3 Johnson & Johnson Tumor Treatment Drug Introduction
    • 11.5.4 Johnson & Johnson Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.5.5 Johnson & Johnson Recent Development
  • 11.6 Merck & Co.
    • 11.6.1 Merck & Co. Company Details
    • 11.6.2 Merck & Co. Business Overview
    • 11.6.3 Merck & Co. Tumor Treatment Drug Introduction
    • 11.6.4 Merck & Co. Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.6.5 Merck & Co. Recent Development
  • 11.7 AstraZeneca
    • 11.7.1 AstraZeneca Company Details
    • 11.7.2 AstraZeneca Business Overview
    • 11.7.3 AstraZeneca Tumor Treatment Drug Introduction
    • 11.7.4 AstraZeneca Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.7.5 AstraZeneca Recent Development
  • 11.8 Pfizer
    • 11.8.1 Pfizer Company Details
    • 11.8.2 Pfizer Business Overview
    • 11.8.3 Pfizer Tumor Treatment Drug Introduction
    • 11.8.4 Pfizer Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.8.5 Pfizer Recent Development
  • 11.9 Amgen
    • 11.9.1 Amgen Company Details
    • 11.9.2 Amgen Business Overview
    • 11.9.3 Amgen Tumor Treatment Drug Introduction
    • 11.9.4 Amgen Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.9.5 Amgen Recent Development
  • 11.10 Eli Lilly
    • 11.10.1 Eli Lilly Company Details
    • 11.10.2 Eli Lilly Business Overview
    • 11.10.3 Eli Lilly Tumor Treatment Drug Introduction
    • 11.10.4 Eli Lilly Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.10.5 Eli Lilly Recent Development
  • 11.11 AbbVie
    • 11.11.1 AbbVie Company Details
    • 11.11.2 AbbVie Business Overview
    • 11.11.3 AbbVie Tumor Treatment Drug Introduction
    • 11.11.4 AbbVie Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.11.5 AbbVie Recent Development
  • 11.12 Takeda
    • 11.12.1 Takeda Company Details
    • 11.12.2 Takeda Business Overview
    • 11.12.3 Takeda Tumor Treatment Drug Introduction
    • 11.12.4 Takeda Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.12.5 Takeda Recent Development
  • 11.13 Astellas
    • 11.13.1 Astellas Company Details
    • 11.13.2 Astellas Business Overview
    • 11.13.3 Astellas Tumor Treatment Drug Introduction
    • 11.13.4 Astellas Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.13.5 Astellas Recent Development
  • 11.14 Ipsen
    • 11.14.1 Ipsen Company Details
    • 11.14.2 Ipsen Business Overview
    • 11.14.3 Ipsen Tumor Treatment Drug Introduction
    • 11.14.4 Ipsen Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.14.5 Ipsen Recent Development
  • 11.15 Sanofi
    • 11.15.1 Sanofi Company Details
    • 11.15.2 Sanofi Business Overview
    • 11.15.3 Sanofi Tumor Treatment Drug Introduction
    • 11.15.4 Sanofi Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.15.5 Sanofi Recent Development
  • 11.16 Bayer
    • 11.16.1 Bayer Company Details
    • 11.16.2 Bayer Business Overview
    • 11.16.3 Bayer Tumor Treatment Drug Introduction
    • 11.16.4 Bayer Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.16.5 Bayer Recent Development
  • 11.17 Biogen Idec
    • 11.17.1 Biogen Idec Company Details
    • 11.17.2 Biogen Idec Business Overview
    • 11.17.3 Biogen Idec Tumor Treatment Drug Introduction
    • 11.17.4 Biogen Idec Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.17.5 Biogen Idec Recent Development
  • 11.18 Teva
    • 11.18.1 Teva Company Details
    • 11.18.2 Teva Business Overview
    • 11.18.3 Teva Tumor Treatment Drug Introduction
    • 11.18.4 Teva Revenue in Tumor Treatment Drug Business (2016-2021)
    • 11.18.5 Teva Recent Development
  • 11.18 Otsuka

.1 Otsuka Company Details

    .2 Otsuka Business Overview

      .3 Otsuka Tumor Treatment Drug Introduction

        .4 Otsuka Revenue in Tumor Treatment Drug Business (2016-2021)

          .5 Otsuka Recent Development

          • 11.20 Eisai
            • 11.20.1 Eisai Company Details
            • 11.20.2 Eisai Business Overview
            • 11.20.3 Eisai Tumor Treatment Drug Introduction
            • 11.20.4 Eisai Revenue in Tumor Treatment Drug Business (2016-2021)
            • 11.20.5 Eisai Recent Development
          • 11.21 Merck KGaA
            • 11.21.1 Merck KGaA Company Details
            • 11.21.2 Merck KGaA Business Overview
            • 11.21.3 Merck KGaA Tumor Treatment Drug Introduction
            • 11.21.4 Merck KGaA Revenue in Tumor Treatment Drug Business (2016-2021)
            • 11.21.5 Merck KGaA Recent Development
          • 11.22 Gilead Sciences
            • 11.22.1 Gilead Sciences Company Details
            • 11.22.2 Gilead Sciences Business Overview
            • 11.22.3 Gilead Sciences Tumor Treatment Drug Introduction
            • 11.22.4 Gilead Sciences Revenue in Tumor Treatment Drug Business (2016-2021)
            • 11.22.5 Gilead Sciences Recent Development

          12 Analyst's Viewpoints/Conclusions

            13 Appendix

            • 13.1 Research Methodology
              • 13.1.1 Methodology/Research Approach
              • 13.1.2 Data Source
            • 13.2 Disclaimer

            Global Tumor Treatment Drug Scope and Market Size
            Tumor Treatment Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Treatment Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

            Segment by Type
            Chemotherapy
            Targeted Therapy
            Immunotherapy (Biologic Therapy)
            Hormonal Therapy
            Others

            Segment by Application
            Blood Cancer
            Breast Cancer
            Gastrointestinal Cancer
            Prostate Cancer
            Respiratory/Lung Cancer
            Others

            By Region
            North America
            United States
            Canada
            Europe
            Germany
            France
            U.K.
            Italy
            Russia
            Nordic
            Rest of Europe
            Asia-Pacific
            China
            Japan
            South Korea
            Southeast Asia
            India
            Australia
            Rest of Asia
            Latin America
            Mexico
            Brazil
            Rest of Latin America
            Middle East & Africa
            Turkey
            Saudi Arabia
            UAE
            Rest of MEA

            By Company
            Roche
            Celgene
            Novartis
            Bristol-Myers Squibb
            Johnson & Johnson
            Merck & Co.
            AstraZeneca
            Pfizer
            Amgen
            Eli Lilly
            AbbVie
            Takeda
            Astellas
            Ipsen
            Sanofi
            Bayer
            Biogen Idec
            Teva
            Otsuka
            Eisai
            Merck KGaA
            Gilead Sciences

            Buy now